Asia-Pacific’s Untapped Potential in mRNA for Cancer Treatment
The Asia-Pacific has emerged as the second largest region for ATMP trials, surpassing Europe and governments across Singapore, South Korea, Australia actively backing up the mRNA innovation. Asia...